Pierre Thadee Victor Kemula
Chief Financial Officer at AgomAb Therapeutics · 3 reported transactions in 1 company · latest trade Oct 6, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Oct 6, 2026 | Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days. | ||
Bought | Oct 6, 2026 | Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days. | ||
Bought | Oct 6, 2026 | Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days. |
BoughtAgomAb Therapeutics
$17.1K
Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days.
BoughtAgomAb Therapeutics
$42.9K
Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days.
BoughtAgomAb Therapeutics
$26K
Oct 6, 2026 close $8.84 → Oct 29, 2026 close $7.95. S&P 500 −0.9% over the same days.